EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies to boost antibody selectivity in oncology

Vincent Blay, Atanasio Pandiella

Trends in Pharmacological Sciences · 2024-12 · 45 (12) · 1135-1149

DOI: 10.1016/j.tips.2024.10.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2024-12. Verfasst von Vincent Blay und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California Santa Cruz, Department of Microbiology and Environmental Toxicology, Santa Cruz, CA 95064, USA. Electronic address: vroger@u…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies in oncology are being equipped with toxic cargoes and effector functions that can kill cells at very low concentrations. A key challenge is that most targets on cancer cells are also present on at least some healthy cells. Shared targets can result in off-tumor binding and compromise the safety and potential of therapeutic candidates. In this review, we survey strategies that can help direct biologics to cancer sites more selectively. These strategies are becoming increasingly feasible thanks to advances in molecular design and engineering. The objective is to create therapeutics that exploit changes in cancer and leverage the human body infrastructure, enabling therapeutics that discriminate not just self from non-self but diseased from healthy tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansAnimalsAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

antibodiesantibody–drug conjugateantigenbiologicscancermultispecificstumor microenvironment

Substanzen

Antineoplastic Agents, Immunological

Autor:innen und Institutionen

  • University of California Santa Cruz, Department of Microbiology and Environmental Toxicology, Santa Cruz, CA 95064, USA. Electronic address: vroger@ucsc.edu.
  • Centro de Investigación del Cáncer, CIBERONC and IBSAL, 37007 Salamanca, Spain.

Zitieren

APA

Blay, V., & Pandiella, A. (2024). Strategies to boost antibody selectivity in oncology. Trends in Pharmacological Sciences, 45(12), 1135-1149. https://doi.org/10.1016/j.tips.2024.10.005

Vancouver

Blay V, Pandiella A. Strategies to boost antibody selectivity in oncology. Trends in Pharmacological Sciences. 2024;45(12):1135-1149. doi:10.1016/j.tips.2024.10.005

BibTeX
@article{Blay2024,
  author = {Blay, Vincent and Pandiella, Atanasio},
  title = {Strategies to boost antibody selectivity in oncology},
  journal = {Trends in Pharmacological Sciences},
  year = {2024},
  volume = {45},
  number = {12},
  pages = {1135--1149},
  doi = {10.1016/j.tips.2024.10.005}
}
Kostenlos starten →